Keywords: UK, NICE, Roche, RoActemra, Rheumatoid arthritis

UK’s NICE asks for more data on Roche’s new drug for rheumatoid arthritis

Article | 16 December 2009

Print This

The UK’s National Institute for Health and Clinical Excellence (NICE)’s independent appraisal committee has asked Swiss drug major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in